Rae Johnson, who has provided his chemistry knowledge and sales talents to ChemDesign since 2004, has been promoted to Senior Vice President of Sales and Marketing.
The following frequently asked questions address fee requirements for manufacturers and importers identified in preliminary lists as fee-obligated entities for the next 20 high priority chemical substances undergoing Toxic Substances Control Act (TSCA) risk evaluations by U.S. Environmental Protection Agency (EPA).
The U.S. Occupational Safety and Health Administration (OSHA) has issued new Enforcement Guidance for Respiratory Protection and the N95 Shortage Due to the Coronavirus Disease 2019 (COVID19) Pandemic. This memorandum is applicable to all industries and provides interim guidance to Compliance Safety and Health Officers (CSHOs) for enforcing the Respiratory Protection standard, 29 CFR § 1910.134, and certain other health standards, with regard to supply shortages of disposable N95 filtering facepiece respirators.
As specialty and fine chemical manufacturers continue to stand on the frontlines, providing valuable and life-sustaining products during this unprecedented time, the Society of Chemical Manufacturers and Affiliates (SOCMA) is providing valuable intelligence and resources to help its members and industry navigate the challenges of the COVID-19 pandemic.
The Society of Chemical Manufacturers & Affiliates (SOCMA) supports federal agency plans to grant temporary enforcement discretion during the COVID-19 pandemic.
The Office of the U.S. Trade Representative (USTR) has announced that USTR is requesting public comments by June 25, 2020 on further modifications to remove Section 301 duties from additional Chinese-origin medical-care products, including pharmaceuticals and chemicals to make pharmaceuticals. SOCMA will submit comments to the docket and as such, requests input from members via the SOCMA 301 COVID-19 Data Sheet (page 3) for inclusion in SOCMA 301 COVID-19 Comments.
Cambrex, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that Troy Player has been appointed as President, Early Stage Development and Testing (ESDT). In his new role, he has responsibility for operations at the Agawam, Massachusetts; Durham, North Carolina; Edinburgh, UK; High Point, North Carolina and Longmont, Colorado facilities.
